The man who inspired the multiple award-winning movie “Jerry Maguire” meets the pioneering stem cell scientist who is ...

PhenQ, the strongest appetite suppressant over the counter (OTC), has officially launched in the United States and ...

Erdem Hospital in Istanbul has announced the launch of a new pre-operative education program tailored specifically for ...

CHICAGO, June 30, 2025 (GLOBE NEWSWIRE) -- Food and nutrition experts from around the world will gather in Nashville, Tenn., October 11-14, for the Academy of Nutrition and Dietetics' 2025 Food & ...

The gross proceeds from the Offering are approximately $19 million, before deducting placement agent fees and other estimated offering expenses. The Company intends to use the net proceeds from the ...

PWR reinforces Jupiter's strategy of monetizing its proprietary science across both pharmaceutical and consumer verticals. The supplement joins GLO in the broader Nugevia ™ rollout, which the Company ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced eight abstracts from its novel clinical development programs, including oral presentations featuring its lead investigational drug ...

The Company expects additional tranches of the Offering to close on or before July 15, 2025.

Pyxis Oncology is providing this information in accordance with Nasdaq Listing Rule 5635 (c) (4).

MANCHESTER, United Kingdom, June 30, 2025 (GLOBE NEWSWIRE) -- Following the roaring success of its annual winter Comedy Tour over the last decade, one of the UK’s leading humanitarian aid charities, ...

Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced it has ...

Aptose Biosciences is a clinical-stage biotechnology company committed to developing precision medicines addressing unmet medical needs in oncology, with an initial focus on hematology. The Company's ...